Amycretin, a new weight loss drug developed by Novo Nordisk, helped participants lose up to 24.3% of body weight in just 36 ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Research shows life expectancy varies up to 20 years based on race, ethnicity, and ZIP code. Learn how data can be used to ...

Despite an increase in the prevalence of prescribing, only 0.5% of U.S. adolescents with obesity were prescribed an obesity ...

Policymakers must prioritize access to innovative obesity care in tackling the obesity epidemic across the United States.

For many, fitness trackers have become indispensable tools for monitoring how many calories they've burned in a day. But for ...

AbbVie Inc. agreed to pay as much as $2.2 billion in March for an amylin drug from Danish biotech Gubra, marking its first foray into the obesity market. New York-based startup Metsera Inc. is ...